AbbVie joins McLaren F1 as official pharmaceutical partner
NXTbets Pro | Published On: October 20, 2026
AbbVie deal
The agreement gives AbbVie its first global sports sponsorship and its first motorsports sponsorship. It brings AbbVie into Formula 1 through McLaren Mastercard F1 Team. The deal is built as more than a simple branding exercise. It gives AbbVie a cause-based message tied to the partnership. For McLaren, the partnership adds another commercial partner. For AbbVie, it marks the company’s entry into Formula 1. The move also fits the way the partnership connects AbbVie to McLaren. The company is entering motorsports through McLaren.
Race to Innovate
The center of the partnership is a cause-related platform called Race to Innovate, and the idea gives the agreement a clear charitable hook. Every 10 constructor points McLaren earns will trigger a $10,000 AbbVie donation to patient-advocacy organizations. That structure links the partnership to results on track and turns points into support off it. The formula is simple, which makes the campaign easy to follow. McLaren scores. AbbVie donates. Patient-advocacy organizations benefit. It is a clean arrangement that gives the team something measurable to build around while giving AbbVie a way to connect its brand with patient support. By tying donations to constructor points, the companies have built a model that rewards performance without making the charitable side feel separate from the racing side. The partnership does not stop at branding on the car. It uses competition itself as the engine for the message. That keeps the focus on McLaren’s results while giving AbbVie a defined role in the partnership. The platform gives both sides a shared narrative built around performance and patient advocacy rather than a one-off promotional push.
McLaren branding
AbbVie branding will appear on the McLaren cars driven by Lando Norris and Oscar Piastri, and it will also appear on each driver’s sleeve when the partnership begins in Austin, Texas, at the United States Grand Prix. McLaren will share its pharma-category sponsorship rights with Sanofi through the end of the year before AbbVie takes exclusivity in the category next year.
